[HTML][HTML] ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour …

C Luchini, F Bibeau, MJL Ligtenberg, N Singh… - Annals of …, 2019 - Elsevier
Background Cancers with a defective DNA mismatch repair (dMMR) system contain
thousands of mutations most frequently located in monomorphic microsatellites and are …

Mismatch repair pathway, genome stability and cancer

N Pećina-Šlaus, A Kafka, I Salamon… - Frontiers in molecular …, 2020 - frontiersin.org
The acquisition of genomic instability is one of the key characteristics of the cancer cell, and
microsatellite instability (MSI) is an important segment of this phenomenon. This review aims …

Predictive biomarkers of colon cancer immunotherapy: Present and future

W Hou, C Yi, H Zhu - Frontiers in immunology, 2022 - frontiersin.org
Immunotherapy has revolutionized colon cancer treatment. Immune checkpoint inhibitors
(ICIs) have shown clinical benefits for colon cancer patients, especially those with high …

NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019: featured updates to the NCCN guidelines

S Gupta, D Provenzale, X Llor, AL Halverson… - Journal of the National …, 2019 - jnccn.org
Identifying individuals with hereditary syndromes allows for improved cancer surveillance,
risk reduction, and optimized management. Establishing criteria for assessment allows for …

Milestones of Lynch syndrome: 1895–2015

HT Lynch, CL Snyder, TG Shaw, CD Heinen… - Nature Reviews …, 2015 - nature.com
Lynch syndrome, which is now recognized as the most common hereditary colorectal cancer
condition, is characterized by the predisposition to a spectrum of cancers, primarily …

[图书][B] Applications of prediction models

EW Steyerberg, EW Steyerberg - 2009 - Springer
Applications of prediction models | SpringerLink Skip to main content Advertisement
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome

V Bonadona, B Bonaïti, S Olschwang, S Grandjouan… - Jama, 2011 - jamanetwork.com
Context Providing accurate estimates of cancer risks is a major challenge in the clinical
management of Lynch syndrome. Objective To estimate the age-specific cumulative risks of …

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

SR Cairns, JH Scholefield, RJ Steele, MG Dunlop… - Gut, 2010 - gut.bmj.com
The British Society of Gastroenterology (BSG) and the Association of Coloproctology for
Great Britain and Ireland (ACPGBI) commissioned this update of the 2002 guidance. The …

The serrated pathway to colorectal carcinoma: current concepts and challenges

M Bettington, N Walker, A Clouston, I Brown… - …, 2013 - Wiley Online Library
Approximately 30% of colorectal carcinomas develop via a serrated neoplasia pathway,
named for the pattern of crypts in the precursor polyps. Molecular abnormalities consistently …

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

A Umar, CR Boland, JP Terdiman… - Journal of the …, 2004 - academic.oup.com
Hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome, is a
common autosomal dominant syndrome characterized by early age at onset, neoplastic …